Glem-Lin MXR (Empagliflozin + Linagliptin + Metformin) 25 mg/ 5 mg/ 1000 mg, 14 Ct - Nabiqasim

Glem-Lin MXR (Empagliflozin + Linagliptin + Metformin) 25 mg/ 5 mg/ 1000 mg, 14 Ct - Nabiqasim
Glem-Lin MXR from Nabiqasim is a maximum-strength, triple-combination therapy designed for comprehensive management of Type 2 Diabetes. Each extended-release tablet contains three powerful medications: Empagliflozin 25 mg (maximum SGLT2 inhibitor dose), Linagliptin 5 mg (DPP-4 inhibitor), and Metformin 1000 mg (Biguanide). This advanced formulation provides robust, multi-mechanism glycemic control in a single once-daily tablet, making it ideal for patients requiring intensive treatment with maximum efficacy.
- Maximum Strength Triple Therapy: Combines the highest recommended dose of
- Empagliflozin with therapeutic doses of Linagliptin and Metformin
Three-Pronged Glucose Control:
- Empagliflozin 25 mg: Maximum SGLT2 inhibition for optimal glucose excretion through urine
- Linagliptin 5mg: Enhances insulin secretion and reduces glucagon production
- Metformin 1000mg XR: Reduces liver glucose production and improves insulin sensitivity
- Cardiovascular & Renal Protection: Empagliflozin provides proven cardiovascular risk reduction and kidney protection benefits
- Extended-Release Advantage: Improved gastrointestinal tolerance with sustained Metformin delivery
- Treatment Simplification: Single-tablet regimen enhances adherence for complex diabetes management
Composition
Each film coated tablet contains:
- Empagliflozin: 25 mg
- Linagliptin: 5 mg
- Metformin HCI USP (as extended release core): 1000 mg
Directions for Use
- As directed by the physician
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Glem-Lin MXR from Nabiqasim is a maximum-strength, triple-combination therapy designed for comprehensive management of Type 2 Diabetes. Each extended-release tablet contains three powerful medications: Empagliflozin 25 mg (maximum SGLT2 inhibitor dose), Linagliptin 5 mg (DPP-4 inhibitor), and Metformin 1000 mg (Biguanide). This advanced formulation provides robust, multi-mechanism glycemic control in a single once-daily tablet, making it ideal for patients requiring intensive treatment with maximum efficacy.
- Maximum Strength Triple Therapy: Combines the highest recommended dose of
- Empagliflozin with therapeutic doses of Linagliptin and Metformin
Three-Pronged Glucose Control:
- Empagliflozin 25 mg: Maximum SGLT2 inhibition for optimal glucose excretion through urine
- Linagliptin 5mg: Enhances insulin secretion and reduces glucagon production
- Metformin 1000mg XR: Reduces liver glucose production and improves insulin sensitivity
- Cardiovascular & Renal Protection: Empagliflozin provides proven cardiovascular risk reduction and kidney protection benefits
- Extended-Release Advantage: Improved gastrointestinal tolerance with sustained Metformin delivery
- Treatment Simplification: Single-tablet regimen enhances adherence for complex diabetes management
Composition
Each film coated tablet contains:
- Empagliflozin: 25 mg
- Linagliptin: 5 mg
- Metformin HCI USP (as extended release core): 1000 mg
Directions for Use
- As directed by the physician
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.











